Marti Technologies, Inc. (NYSE:MRT), which merged with Galata Acquisition Corp. in July, announced this afternoon that it has launched an exchange offer to purchase its Class A ordinary shares for $0.10 in cash.
The company is also soliciting consents to amend the warrant agreement to redeem each warrant that is not tendered in connection with the offer for $0.07 in cash, without interest, which is 30% less than the price applicable to the offer. As of November 21, a total of 14,437,489 warrants were outstanding.
Parties representing approximately 26% of the outstanding public warrants and 95% of the outstanding private warrants have already agreed to tender their warrants and consent to the amendment.
If an additional 34% of the outstanding public warrants consent to the amendment and it is adopted, then Marti will redeem the remaining outstanding warrants. This would result in the holders of any remaining outstanding warrants receiving approximately 30% less cash than if they had tendered their warrants in the offer.
Holders have until midnight on December 19 to do so, unless extended or earlier terminated by Marti.
The company expects the offer to reduce the number of ordinary shares that would become outstanding upon the exercise of warrant, providing investors with greater certainty to its capital structure.
Galata inked its $532 million business combination with Marti in August 2022 and completed the combination in July 2023. Istanbul, Turkey-based Marti operates a fleet of over 46,000 e-mopeds, e-bikes, and e-scooters, serviced by proprietary software systems and IoT infrastructure.
Perimeter Acquisition Corp. I (NASDAQ:PMTRU) announced the pricing of its upsized $210 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “PMTRU”, Tuesday, May 13, 2025. The new SPAC aims to combine with a target company with that can contribute to the re-industrialization of the United States economy,...
Horizon Space II (NASDAQ:HSPT) has signed a definitive agreement to combine with clinical stage biotech firm SL Bio Ltd. for $5.57 billion in equity consideration. Taipei, Taiwan-based SL Bio is developing drug candidates to treat several cancer types while also selling over-the-counter beauty products derived from natural extracts. The combined company is expected to trade...
At the SPAC of Dawn This is set to be a slower week for votes with just two SPACs seeking an extension and none yet scheduling a meeting for approving a business combination. Integrated Rail & Resources (OTC:IRRX) primed the pump somewhat for investors ahead of its Tuesday special meeting by announcing it has entered...
Terms Tracker for the Week Ending May 9, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. After the sprint that was last week, with nine IPOs and six new SPAC filings, this week took a breather. Only two SPACs priced, there...
Lake Superior (NASDAQ:LKSPU) has filed for a $100 million SPAC as its CEO attempts to go three-for-three with SPACs that led to completed deals. This new vehicle has one right to a 1/6 share in each unit and some common features of a SPAC underwritten by Cohen & Company in this current climate. Although the...